 |
 |
| DISSS Home | Contact Us |
| ||||||||
|
|
|
|
|
|
| ||
|
|
| ||||||
.gif){kind=spacer} 
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||
|
| ||||||||||||||||||||||||||||||||||||
Bayer R, Fairchild AL. Public health: surveillance and privacy. Science 2000;290:1898--9.
Chin JE, ed. Control of communicable diseases manual. 17th ed. Washington, DC: American Public Health Association, 2000.
Freimuth V, Linnan HW, Potter P. Communicating the threat of emerging infections to the public. Emerg Infect Dis 2000;6:337--47.
Lin SS, Kelsey JL. Use of race and ethnicity in epidemiologic research: concepts, methodological issues, and suggestions for research. Epidemiol Rev 2000;22:187--202.
Pinner RW, Jernigan DB, Sutliff SM. Electronic laboratory-based reporting for public health. Military Medicine 2000;165(suppl 2):20--4.
Pinner RW, Koo D, Berkelman RL. Surveillance of infectious diseases. In: Lederberg J, Alexander M, Bloom RB, eds. Encyclopedia of microbiology. 2nd ed. San Diego, CA: Academic Press, 2000;4:506--25.
Teutsch SM, Churchill RE, eds. Principles and practice of public health surveillance. 2nd ed. New York, NY: Oxford University Press, 2000.
CDC. Framework for program evaluation in public health. MMWR 1999;48(No. RR-11).
CDC. Manual for the surveillance of vaccine preventable diseases. Atlanta, GA: CDC, 1999. Available at <http://www.cdc.gov/nip/publications/surv-manual/begin.pdf>.
CDC. Reporting race and ethnicity data---National Electronic Telecommunications System for Surveillance, 1994--1997. MMWR 1999;48:305--12.
CDC. Sexually transmitted disease surveillance 1998. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC, 1999.
Effler P, Ching-Lee M, Bogard A, Ieong MC, Nekomoto T, Jernigan D. Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods. JAMA 1999;282:1845--50. Abstract available at <http://jama.ama-assn.org/issues/v282n19/abs/joc90534.html>.
Koo D, Caldwell B. The role of providers and health plans in infectious disease surveillance. Eff Clin Pract 1999;2:247--52. Available at <http://www.acponline.org/journals/ecp/sepoct99/koo.htm>.
Roush S, Birkhead G, Koo D, Cobb A, Fleming D. Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA 1999;282:164--70. Available at <http://jama.ama-assn.org/issues/v282n2/abs/joc90413.html>.
Niskar AS, Koo D. Differences in notifiable infectious disease morbidity among adult women---United States, 1992--1994. J Womens Health 1998;7:451--8.
CDC. Case definitions for infectious conditions under public health surveillance. MMWR 1997;46(No. RR-10).
CDC. Demographic differences in notifiable infectious disease morbidity---United States, 1992--1994. MMWR 1997;46:637--41.
CDC. Historical perspectives: notifiable disease surveillance and notifiable disease statistics---United States, June 1946 and June 1996. MMWR 1996;45:530--6.
CDC. Ten leading nationally notifiable infectious diseases---United States, 1995. MMWR 1996;45:883--4.
Koo D, Wetterhall S. History and current status of the National Notifiable Diseases Surveillance System. J Public Health Manag Pract 1996;2:4--10.
CDC. Manual of procedures for the reporting of nationally notifiable diseases to CDC. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC, 1995.
Martin SM, Bean NH. Data management issues for emerging diseases and new tools for managing surveillance and laboratory data. Emerg Infect Dis 1995;1:124--8. Available at <http://www.cdc.gov/ncidod/eid/vol1no4/martin2.htm#top>.
Thacker SB, Stroup DF. Future directions for comprehensive public health surveillance and health information systems in the United States. Am J Epidemiol 1994;140:383--97.
CDC. Proceedings of the 1992 International Symposium on Public Health Surveillance. MMWR 1992;41(suppl).
CDC. Mandatory reporting of infectious diseases by clinicians and mandatory reporting of occupational diseases by clinicians. MMWR 1990;39(No. RR-9).
Thacker SB, Choi K, Brachman PS. The surveillance of infectious diseases. JAMA 1983;249:1181--5.
CDC. HIV and AIDS---United States, 1981--2000. MMWR 2001;50:430--4.
CDC. Successful implementation of perinatal HIV prevention guidelines---a multistate surveillance evaluation. MMWR 2001;50(No. RR-6):15--28.
Karon JM, Fleming PL, Steketee RW, De Cock KM. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001;91:1060--8.
CDC. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR 1999;48(No. RR-13):1--11.
Angulo FJ, Getz J, Taylor JP, et al. A large outbreak of botulism: the hazardous baked potato. J Infect Dis 1998;178:172--7.
CDC. Botulism in the United States, 1899--1996: handbook for epidemiologists, clinicians, and laboratory workers. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC, 1998. Available at <http://www.cdc.gov/ncidod/dbmd/diseaseinfo/botulism.pdf>. Requires Adobe Acrobat Reader - available here.
Shapiro RL, Hatheway C, Becher J, Swerdlow D. Botulism surveillance and emergency response: a public health strategy for a global challenge. JAMA 1997;278:433--5.
Yagupsky P. Detection of brucellae in blood cultures. J Clin Microbiol 1999;37:3437--42.
CDC. Human exposure to Brucella abortus strain RB51---Kansas, 1997. MMWR 1998;47:172--5.
Chomel BB, DeBess EE, Mangiamele DM, et al. Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: a shift toward foodborne transmission. J Infect Dis 1994;170:1216--23.
Taylor JP, Perdue JN. The changing epidemiology of human brucellosis in Texas, 1977--1986. Am J Epidemiol 1989;130:160--5.
Mertz KJ, Trees D, Levine WC, et al. Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. The Genital Ulcer Disease Surveillance Group. J Infect Dis 1998;178:1795--8.
Mertz KJ, Weiss JB, Webb RM, et al. An investigation of genital ulcers in Jackson, Mississippi, with use of a multiplex polymerase chain reaction assay: high prevalence of chancroid and human immunodeficiency virus infection. J Infect Dis 1998;178:1060--6.
DiCarlo RP, Armentor BS, Martin DH. Chancroid epidemiology in New Orleans men. J Infect Dis 1995;172:446--52.
CDC. Chlamydia trachomatis genital infections---United States, 1995. MMWR 1997;46:193--8.
CDC. Sexually transmitted disease surveillance 2000 supplement: Chlamydia Prevalence Monitoring Project. Atlanta, GA: US Department of Health and Human Services, CDC, November 2001.
Gaydos CA, Howell MR, Pare B, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998;339:739--44.
Mertz KJ, McQuillan GM, Levine WC, et al. A pilot study of chlamydial infection in a national household survey. Sex Transm Dis 1998;25:225--8.
Mintz ED, Tauxe RV, Levine MM. The global resurgence of cholera. In: Noah ND, O'Mahony M, eds. Communicable disease epidemiology and control. Chichester, England: John Wiley & Sons, 1998:63--104.
Mahon BE, Mintz ED, Greene KD, Wells JG, Tauxe RV. Reported cholera in the United States, 1992--1994: a reflection of global changes in cholera epidemiology. JAMA 1996;276:307--12.
Wachsmuth IK, Blake PA, Olsvik O, eds. Vibrio cholerae and cholera: molecular to global perspectives. Washington, DC: American Society for Microbiology, 1994.
World Health Organization. Guidelines for cholera control. Geneva, Switzerland: World Health Organization, 1993.
Lopez AS, Dodson DR, Arrowood MJ, et al. Outbreak of cyclosporiasis associated with basil in Missouri in 1999. Clin Infect Dis 2001;32:1010--7.
Herwaldt BL. Cyclospora cayetanensis: a review, focusing on the outbreaks of cyclosporiasis in the 1990s. Clin Infect Dis 2000;31:1040--57.
Herwaldt BL, Beach MJ. The return of Cyclospora in 1997: another outbreak of cyclosporiasis in North America associated with imported raspberries. Cyclospora Working Group. Ann Intern Med 1999;130:210--20.
Herwaldt BL, Ackers ML. An outbreak in 1996 of cyclosporiasis associated with imported raspberries. The Cyclospora Working Group. N Engl J Med 1997;336:1548--56.
Dittmann S, Wharton M, Vitek C, et al. Successful control of epidemic diphtheria in the states of the former Union of Soviet Socialist Republics: lessons learned. J Infect Dis 2000;181 (suppl 1):S10--S22.
Bisgard KM, Hardy IR, Popovic T, et al. Respiratory diphtheria in the United States, 1980 through 1995. Am J Public Health 1998;88:787--91.
Galazka AM, Robertson SE. Diphtheria: changing patterns in the developing world and the industrialized world. European J Epidemiol 1995;11:107--17.
Belongia EA, Reed KD, Mitchell PD, et al. Tickborne infections as a cause of nonspecific febrile illness in Wisconsin. Clin Infect Dis 2001;32:1434--9.
IJdo JW, Meek JI, Cartter ML, et al. The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. J Infect Dis 2000;181:1388--93.
Childs JE, Sumner JW, Nicholson WL, Massung RF, Standaert SM, Paddock CD. Outcome of diagnostic tests using samples from patients with culture-proven human monocytic ehrlichiosis: implications for surveillance. J Clin Microbiol 1999;37:2997--3000.
McQuiston JH, Paddock CD, Holman RC, Childs JE. The human ehrlichioses in the United States [Review]. Emerg Infect Dis 1999;5:635--42. Available at <http://www.cdc.gov/ncidod/eid/vol5no5/mcquiston.htm>.
CDC. Human West Nile virus surveillance---Connecticut, New Jersey, and New York, 2000. MMWR 2001;50:265--8.
CDC. Notice to readers: revision of guidelines for surveillance, prevention, and control of West Nile virus infection. MMWR 2001;50:273.
CDC. Arboviral infections of the central nervous system---United States, 1996--1997. MMWR 1998;47:517--22.
Banatvala N, Griffin PM, Greene KD, et al. The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis 2001;183:1063--70.
CDC. Escherichia coli O111:H8 outbreak among teenage campers---Texas, 1999. MMWR 2000;49:321--4.
Mahon BE, Griffin PM, Mead PS, Tauxe RV. Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli [Letter]. Emerg Infect Dis 1997;3:409--12. Available in the Internet at <http://www.cdc.gov/ncidod/eid/vol3no3/mahon.htm>.
Siegler RL, Pavia AT, Christofferson RD, Milligan MK. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics 1994;94:35-40.
CDC. Sexually transmitted diseases surveillance 2000 supplement: Gonococcal Isolate Surveillance Project (GISP) annual report---2000. Atlanta, GA: US Department of Health and Human Services, CDC, October 2001.
Fox KK, del Rio C, Holmes KK, et al. Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. Am J Public Health 2001;91:959--64.
CDC. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 2000. MMWR 2000;49:833--7.
CDC. Gonorrhea---United States, 1998. MMWR 2000;49:538--42.
Galil K, Singleton R, Levine OS, et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis 1999;179:101--6.
Bisgard KM, Kao A, Leake J, Strebel PM, Perkins BA, Wharton M. Haemophilus influenzae invasive disease in the United States, 1994--1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis 1998;2:229-37. Available at <http://www.cdc.gov/ncidod/eid/vol4no2/bisgard.htm>.
CDC. Progress toward eliminating Haemophilus influenzae type b disease among infants and children---United States, 1987--1997. MMWR 1998;47:993--8.
CDC. Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1993;42(No. RR-13).
Glass G, Cheek J, Patz J, et al. Using remotely sensed data to identify areas at risk for hantavirus pulmonary syndrome. Emerg Infect Dis 2000;6:238--47. Available at <http://www.cdc.gov/ncidod/eid/vol6no3/glass.htm>.
Hjelle B, Glass G. Outbreak of hantavirus infection in the four corners region of the United States in the wake of the 1997--1998 El Nino-Southern Oscillation. J Infect Dis 2000;181:1569--73. Available at <http://www.journals.uchicago.edu/JID/journalChapman LE, Mertz GJ, Peters CJ, et al. Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Antiviral Therapy 1999;4:211--9.
Kitsutani PI, Denton RW, Fritz CL, et al. Acute Sin Nombre hantavirus infection without pulmonary syndrome, United States. Emerg Infect Dis 1999;5:701--5. Available at <http://www.cdc.gov/ncidod/eid/vol5no5/kitsutani.htm>.
CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(No. RR-12).
Bell BP, Shapiro CN, Alter MJ, et al. The diverse patterns of hepatitis A epidemiology in the United States---implications for vaccination strategies. J Infect Dis 1998;178:1579--84.
Lemon SM, Shapiro CN. The value of immunization against hepatitis A. Infect Agents Dis 1994;3:38--49.
Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA. Vaccine 1992;10(suppl 1):S59--S62.
McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Pub Health 1999;89:14--8.
Coleman PJ, McQuillan GM, Moyer LA, Lambert SB, Margolis HS. Incidence of hepatitis B virus infection in the United States, 1976--1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis 1998;178:954--9.
CDC. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991;40(No. RR-13):1-19.
Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control [Review]. Semin Liver Dis 1991;11:84--92.
Armstrong GA, Alter MJ, McQuillan GM, Margolis HS. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States. Hepatology 2000;31:777--82.
Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556--62.
CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47(No. RR-19).
CDC. HIV and AIDS---United States, 1981--2000. MMWR 2001;50:430--4.
CDC. Successful implementation of perinatal HIV prevention guidelines---multistate surveillance evaluation. MMWR 2001;50(No. RR-6):15--28.
CDC. US HIV and AIDS cases reported through June 2000. Mid-year edition. HIV/AIDS Surveillance Report 2000;12(No. 1):1--42.
Lindegren ML, Steinberg S, Byers RH, Jr. Epidemiology of HIV/AIDS in children. Pediatr Clin N Am 2000;47:1--20.
CDC. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR 1999;48(No. RR-13):1--11.
CDC. Lyme disease---United States, 1999. MMWR 2001;50:181--5.
Orloski KA, Hayes EB, Campbell GL, Dennis DT. Surveillance for Lyme disease---United States, 1992--1998. In: CDC Surveillance Summaries. MMWR 2000;49(No. SS-3):1--11.
CDC. Recommendations for the use of Lyme disease vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(No. RR-7):1--24.
Hayes EB, Maupin GO, Mount GA, Piesman J. Assessing the prevention effectiveness of local Lyme disease control. J Public Health Manag Pract 1999;5:84--92.
Lobel HO, Kozarsky PE. Update on prevention of malaria for travelers. JAMA 1997;278:1767--71.
Zucker JR. Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks. Emerg Infect Dis 1996;2:37--43. Available at <http://www.cdc.gov/ncidod/eid/vol2no1/zuckerei.htm>.
Zucker JR, Campbell CC. Malaria: principles of prevention and treatment [Review]. Infect Dis Clin North Am 1993;7:547--67.
CDC. Measles---United States, 1999. MMWR 2000;49:557--60.
CDC. Epidemiology of measles---United States, 1998. MMWR 1999;48:749--53.
CDC. Measles, mumps and rubella---vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1998;47(No. RR8).
CDC. Measles---United States, 1997. MMWR 1998;47:273--6.
CDC. Prevention and control of meningococcal disease, and meningococal disease and college students: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000;49(No. RR-7).
CDC. Serogroup W-135 meningococcal disease among travelers returning from Saudi Arabia—United States, 2000. MMWR 2000;49:345-6.
Diermayer M, Hedberg K, Hoesly FC, et al. Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain. JAMA 1999;281:1493--7. Available at <http://jama.ama-assn.org/issues/v281n16/rfull/joc81215.html>.
Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992--1996. J Infect Dis 1999;180:1894--901.
CDC. Mumps surveillance United States, 1988--1993. MMWR 1995;44(No. SS-3).
Briss PA, Fehrs LJ, Parker RA, et al. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity. J Infect Dis 1994;169:77--82.
Hersh BS, Fine PE, Kent WK, et al. Mumps outbreak in a highly vaccinated population. J Pediatr 1991;119:187--93.
CDC. Recommendations of the Immunization Practices Advisory Committee on Mumps prevention. MMWR 1989;38:388--92, 397--400.
Bisgard KM, Christie CD, Reising SF, et al. Molecular epidemiology of Bordetalla pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989--1996. J Inf Dis 2001;183:1360--7.
Strebel P, Nordin J, Edwards K, et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995--1996. J Inf Dis 2001;183:1353--9.
Guris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990--1996. Clin Infect Dis 1999;28:1230--7.
CDC. Notice to readers: FDA approval of a fourth acellular pertussis vaccine for use among infants and young children. MMWR 1998;47:934--6.
Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense [Review]. JAMA 2000;283:2281--90.
Dennis DT, Gage KL, Gratz N, Poland JD, Tikhomirov E. Plague manual: epidemiology, distribution, surveillance and control. Geneva, Switzerland: World Health Organization, 1999.
Poland JD, Dennis DT. Plague. In: Evans AS, Brachman PS, eds. Bacterial infections of humans: epidemiology and control. 3rd ed. New York, NY: Plenum Medical Book Company, 1998:545--58.
CDC. Poliomyelitis prevention in the United States: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000;49(No. RR-5).
Prevots DR, Khetsuriani N, Wharton M. Evidence for a decline in the number of vaccine-associated paralytic poliomyelitis cases in the United States following implementation of a sequential poliovirus vaccination schedule, 1997--1998. Presented at the 36th annual meeting of the Infectious Disease Society of America, November 12--15, 1998.
Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med 1994;148:479--85.
Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985--1998. Clinical and epidemiologic features of 1,383 infections. Medicine 2000:79:109--23.
Tissot-Dupont H, Torres S, Nezri M, Raoult D. Hyperendemic focus of Q fever related to sheep and wind. Am J Epi 1999;150:67--74.
CDC. Q fever outbreak---Germany, 1996. MMWR 1997;46:29--32.
Bernard KW, Parham GL, Winkler WG, Helmick CG. Q fever control measures: recommendations for research facilities using sheep. Infection Control 1982;3:461--5.
CDC. Compendium of animal rabies prevention and control, 2001: National Association of State and Territorial Public Health Veterinarians, Inc. MMWR 2001;50(No. RR-8).
Krebs JW, Rupprecht CE, Childs JE. Rabies surveillance in the United States during 1999. J Am Vet Med Assoc 2000;217:1799--811. Available at <http://www.cdc.gov/ncidod/dvrd/rabies/ professional/Surveillance99/index.htm>.
CDC. Human rabies prevention---United States, 1999: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(No. RR-1).
Noah DL, Drenzek CL, Smith JS, et al. Epidemiology of human rabies in the United States, 1980 to 1996 [Review]. Ann Intern Med 1998;128:922--30.
CDC. Consequences of delayed diagnosis of Rocky Mountain spotted fever in children---West Virginia, Michigan, Tennessee, and Oklahoma, May--July 2000. MMWR 2000;49:885--8.
Treadwell TA, Holman RC, Clarke MA, Krebs JW, Paddock CD, Childs JE. Rocky Mountain spotted fever in the United States, 1993--1996. Am J Trop Med Hyg 2000;63:21--6.
Paddock CD, Greer PW, Ferebee TL, et al. Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed diseases. J Infect Dis 1999;179:1469--76.
Dalton MJ, Clarke MJ, Holman RC, et al. National surveillance for Rocky Mountain spotted fever, 1981--1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995;52:405--13.
CDC. Control and prevention of rubella: evaluation and management of suspected rubella outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR 2001;50(No. RR-12):1--23.
CDC. Rubella among Hispanic adults---Kansas, 1998, and Nebraska, 1999. MMWR 2000;49:225--8.
Danovaro-Holliday MC, LeBaron CW, Allensworth C, et al. A large rubella outbreak with spread from the workplace to the community. JAMA 2000;284:2733--9.
Reef S, Plotkin S, Cordero J, et al. Preparing for congenital rubella syndrome elimination: summary of the Workshop on Congenital Rubella Syndrome Elimination in the United States. Clin Infect Dis 2000;31:85--95.
Olsen SJ, Bishop R, Brenner FW, et al. The changing epidemiology of Salmonella: trends in serotypes isolated from humans in the United States, 1987--1997. J Infect Dis 2001;183:753--61.
Mahon BE, Slusker L, Hutwagner L, et al. Consequences in Georgia of a nationwide outbreak of Salmonella infections: what you don't know might hurt you. Am J Public Health 1999;89:31--5.
Van Beneden CA, Keene WE, Strang RA, et al. Mutinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts. JAMA 1999;281:158--62.
Glynn MK, Bopp C, Dewitt WK, Dabney P, Moktar M, Angulo FJ. Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 infections in the United States. N Engl J Med 1998;338:1333--8.
CDC. Outbreak of gastroenteritis associated with an interactive water fountain at a beachside park---Florida, 1999. MMWR 2000;49:565--8.
CDC. Outbreaks of Shigella sonnei infection associated with eating fresh parsley---United States and Canada, July--August 1998. MMWR 1999;48:285--9.
Sobel J, Cameron DN, Ismail J, et al. A prolonged outbreak of Shigella sonnei infections in traditionally observant Jewish communities in North America caused by a molecularly distinct bacterial subtype. J Infect Dis 1998;177:1405--8.
Mohle-Boetani JC, Stapleton M, Finger R, et al. Communitywide shigellosis: control of an outbreak and risk factors in child day-care centers. Am J Public Health 1995;85:812--6.
CDC. Active Bacterial Core Surveillance (ABCs) report. Emerging Infections Program Network. Group A streptococcus, 2000 (preliminary). Atlanta, GA: US Department of Health and Human Services, CDC, 2000.
Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics 2000;105:E60.
CDC. Nosocomial group A streptococcal infections associated with asymptomatic health-care workers---Maryland and California, 1997. MMWR 1999;48:163--6.
Anonymous. Prevention of invasive group A streptococcal disease among household contacts of case-patients: is prophylaxis warranted? The Working Group on Prevention of Invasive Group A Streptococcal Infections. JAMA 1998;279:1206--10.
Robinson KA, Baughman W, Rothrock G, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995--1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001;285:1729--35.
CDC. Prevention of pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices. MMWR 2000;49(No. RR-9):1--35.
Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000;343:1917--24.
CDC. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997;46(No. RR-8):1--24.
CDC. Congenital syphilis---United States, 2000. MMWR 2001;50:573--7.
Southwick KL, Guidry HM, Weldon MM, Mertz KJ, Berman SM, Levine WC. An epidemic of congenital syphilis in Jefferson County, Texas, 1994--1995: inadequate prenatal syphilis testing after an outbreak in adults. Am J Public Health 1999;89:557--60.
CDC. Guidelines for the prevention and control of congenital syphilis. MMWR 1988;37(No. S-1).
CDC. Primary and secondary syphilis---United States, 1999. MMWR 2001;50:113--7.
CDC. Sexually transmitted disease surveillance supplement 2000: syphilis surveillance report. Atlanta, GA: US Department of Health and Human Services, CDC, December 2001.
CDC. Outbreak of syphilis among men who have sex with men---Southern California, 2000. MMWR 2001;50:117--20.
CDC. The national plan to eliminate syphilis from the United States. Atlanta, GA: US Department of Health and Human Services, CDC, October 1999.
Bardenheier B, Prevots DR, Khetsuriani N, Wharton M. Tetanus surveillance---United States, 1995--1997. In: CDC surveillance summaries, July 3, 1998. MMWR 1998;47(No. SS2):1--13.
CDC. Neonatal tetanus---Montana, 1998. MMWR 1998;47:928--30.
CDC. Tetanus among injecting drug users---California, 1997. MMWR 1998;47:149--51.
Gergen PJ, McQuillan GM, Kiely M, EzzatiRice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995;332:761--6.
Hajjeh RA, Reingold R, Weil A, Shutt K, Schuchat A, Perkins BA. Toxic shock syndrome in the United States: surveillance update, 1979--1996. Emerg Infec Dis 1999;5:807--10. Available at <http://www.cdc.gov/ncidod/eid/vol5no6/hajjeh.htm>.
Schuchat A, Broome CV. Toxic shock syndrome and tampons. Epidemiol Rev 1991;13:990112.
CDC. Reduced incidence of menstrual toxicshock syndrome---United States, 1980--1990. MMWR 1990;39:421--3.
Gaventa S, Reingold AL, Hightower AW, et al. Active surveillance for toxic shock syndrome in the United States, 1986. Rev Infect Dis 1989;11(suppl):S28--S34.
CDC. Reported tuberculosis in the United States, 2000. Atlanta, GA: US Department of Health and Human Services, CDC, August 2001. Available at <http://www.cdc.gov/nchstp/tb/>.
Institute of Medicine. Ending neglect: the elimination of tuberculosis in the United States. Washington, DC: National Academy Press, 2000. Available at <http://www.nap.edu/books/0309070287/html/>.
Talbot EA, Moore M, McCray E, Binkin NJ. Tuberculosis among foreign-born persons in the United States, 1993--1998. JAMA 2000;284:2894--900.
CDC. Essential components of a tuberculosis prevention and control program: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1995;44(No. RR-11):1--17.
Moorhead A, Grunenwald PE, Dietz VJ, Schantz PM. Trichinellosis in the United States, 1991--1996: declining but not gone. Am J Trop Med Hyg 1999;60:66--9.
CDC. Outbreak of trichinellosis associated with eating cougar jerky---Idaho, 1995. MMWR 1996;45:205--6.
McAuley JB, Michelson MK, Schantz PM. Trichinosis surveillance, United States, 1987--1990. In: CDC surveillance summaries, December 1991. MMWR 1991;40(No. SS-3):35-42.
Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001;285:2763--73.
Ackers ML, Puhr ND, Tauxe RV, Mintz ED. Laboratorybased surveillance of Salmonella Serotype Typhi infections in the United States: antimicrobial resistance on the rise. JAMA 2000;283:2668--73.
Mermin JH, Villar R, Carpenter J, et al. A massive epidemic of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water. J Infect Dis 1999;179:1416--22.
Mermin JH, Townes JM, Gerber M, Dolan N, Mintz ED, Tauxe RV. Typhoid fever in the United States, 1985--1994: changing risks of international travel and increasing antimicrobial resistance. Arch Intern Med 1998;158:633--8.
CDC. Typhoid immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1994;43(No. RR-14).
CDC. Evaluation of varicella reporting to the National Notifiable Disease Surveillance System---United States, 1972--1997. MMWR 1999;48;55--8.
CDC. Prevention of varicella: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(No. RR-6).
CDC. Varicella-related deaths---Florida, 1998. MMWR 1999;48:379--81.
CDC. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45(No. RR-11):1--25.
 |
|
|
|
|
Privacy Policy | Accessibility CDC Home | Search | Health Topics A-Z This page last updated January 9, 2008 United States
Department of Health and Human Services "Epi Info" is a trademark of the Centers for Disease Control and Prevention (CDC). |
